首页> 外国专利> LIGAND-GUIDED PHAGOCYTOSIS BASED THERAPY FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES

LIGAND-GUIDED PHAGOCYTOSIS BASED THERAPY FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES

机译:配体导向的基于吞噬作用的疗法,用于治疗老年痴呆症和其他神经退行性疾病

摘要

Disclosed are conjugates and compositions comprising an amyloid beta binding protein conjugated to a MerTK ligand. Disclosed are methods of clearing amyloid beta aggregates from a subject comprising administering a therapeutically effective amount of the conjugates and compositions comprising an amyloid beta binding protein conjugated to a MerTK ligand. Disclosed are methods of treating Alzheimer's Disease comprising administering to a subject in need thereof a therapeutically effective amount of conjugates and compositions comprising an amyloid beta binding protein conjugated to a MerTK ligand.
机译:公开了包含与MerTK配体缀合的淀粉状蛋白β结合蛋白的缀合物和组合物。公开了从受试者清除淀粉状蛋白β聚集体的方法,其包括施用治疗有效量的缀合物和包含与MerTK配体缀合的淀粉状蛋白β结合蛋白的组合物。公开了治疗阿尔茨海默氏病的方法,该方法包括给予有需要的受试者治疗有效量的缀合物和包含与MerTK配体缀合的淀粉状蛋白β结合蛋白的组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号